COLUSSI, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 10.079
EU - Europa 3.152
AS - Asia 838
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 5
SA - Sud America 3
OC - Oceania 2
Totale 14.099
Nazione #
US - Stati Uniti d'America 10.029
UA - Ucraina 1.111
IT - Italia 764
CN - Cina 461
DE - Germania 450
FI - Finlandia 349
IE - Irlanda 195
SG - Singapore 172
SE - Svezia 110
TR - Turchia 108
VN - Vietnam 48
CA - Canada 47
GB - Regno Unito 41
FR - Francia 39
BE - Belgio 21
EU - Europa 19
RU - Federazione Russa 19
IR - Iran 16
CZ - Repubblica Ceca 14
IN - India 11
KR - Corea 10
NL - Olanda 7
AT - Austria 6
JP - Giappone 5
EE - Estonia 4
CH - Svizzera 3
PL - Polonia 3
RO - Romania 3
TG - Togo 3
AU - Australia 2
BT - Bhutan 2
HK - Hong Kong 2
ME - Montenegro 2
MX - Messico 2
PT - Portogallo 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
ES - Italia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
LT - Lituania 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 14.099
Città #
Woodbridge 1.428
Fairfield 1.110
Ann Arbor 912
Jacksonville 795
Chandler 594
Houston 573
Ashburn 528
Dearborn 501
Wilmington 494
Seattle 450
Cambridge 370
Boardman 282
Princeton 217
Dublin 193
Beijing 179
Udine 148
Singapore 127
Izmir 107
San Diego 83
Des Moines 48
Ogden 48
Dong Ket 47
Hefei 44
Norwalk 44
Redmond 42
Ottawa 39
Nanjing 37
Milan 35
Rome 32
San Mateo 32
Kunming 30
Guangzhou 23
Brussels 21
Helsinki 18
Trieste 17
Mcallen 13
Brno 12
Grafing 12
Falls Church 11
Shanghai 11
Jinan 10
Washington 10
Bologna 9
Fuzhou 9
Pignone 9
Turin 9
Vicenza 9
Indiana 8
Munich 8
Phoenix 8
Wuhan 8
Los Angeles 7
Hangzhou 6
Hebei 6
Leawood 6
Nanchang 6
New York 6
Tavagnacco 6
Torre Del Greco 6
Ancona 5
Castellammare Di Stabia 5
Henderson 5
Palermo 5
Saint Petersburg 5
Simi Valley 5
Venezia 5
Verona 5
Vienna 5
Xian 5
Zanjan 5
Zhengzhou 5
Andover 4
Bari 4
Fontanafredda 4
Lanzhou 4
Mascali 4
Mumbai 4
Nanning 4
Naples 4
Paris 4
San Giuseppe Vesuviano 4
Shenyang 4
Taizhou 4
Tallinn 4
West Jordan 4
Winnipeg 4
Ardabil 3
Baotou 3
Catania 3
Changsha 3
Chengdu 3
Ferrara 3
Kashan 3
Lomé 3
Maserada Sul Piave 3
Murano 3
Nürnberg 3
Potenza 3
Pune 3
Sacramento 3
Totale 10.015
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 238
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 159
Aldosterone and the heart: from basic research to clinical evidence 144
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 143
Aldosterone and Left Ventricular Remodeling 139
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 135
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 126
Aldosterone, Organ Damage, and Dietary Salt 125
Aldosterone and the heart: still an unresolved issue? 124
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 121
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 121
The emergent cardiovascular risk factors and organ damage in arterial hypertension 118
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 117
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 116
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 116
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 116
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 115
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 115
Treatment of primary aldosteronism and organ protection 115
Benzodiazepines: an old class of new antihypertensive drugs? 114
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 114
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 112
Kidney in primary aldosteronism: a key determinant of treatment outcome 111
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 111
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 110
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 110
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 109
Salt, hypertension, and cardiovascular disease 108
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 108
Cardiovascular outcomes in patients with primary aldosteronism after treatment 107
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 107
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 105
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 105
Renal function in primary aldosteronism 102
Potassium-sparing diuretics in hypertension 102
Diabetes, diabetic complications, and blood pressure targets 102
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 102
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 102
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 101
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 100
Hypertension and type 2 diabetes: lights and shadows about causality 100
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 99
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 99
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 98
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 98
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 96
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 95
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 95
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 94
Uricaemia and left ventricular mass in hypertensive patients 94
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 93
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 92
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 92
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 91
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 90
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 90
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 90
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 90
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 90
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 89
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 88
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 88
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 88
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 87
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 86
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: Response to Perciaccante et al. [4] 86
Relationships of plasma renin with renal function in primary aldosteronism: revisiting the concept of renin escape 85
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 84
Omega-3 polyunsaturated fatty acids in blood pressure control and essential hypertension 82
Alpha-adducin gene polymorphism predicts cardiac and vascular response to treatment in hypertensive women 79
Studio della funzione endoteliale in pazienti con steatosi epatica non-alcolica. 78
Hyperaldosteronism and Left Ventricular Hypertrophy 78
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 78
Association of elevated levels of PAI-1 with insulin resistance and inflammatory markers in hypertension. 77
Ambulatory blood pressure and left ventricular geometry in patients with myotonic dystrophy 77
Effects of n-3 polyunsatured fatty acids (PUFA) on markers of oxidative stress in hypertension 76
The carotid intima-media thickness and cardiac tissue Doppler in hypertension 75
Association of a prothrombotic state with carotid intima-media thickness in hypertensive patients 75
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism 74
The new cardiovascular risk factors in hypertensive patients with metabolic syndrome 74
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 74
Metabolic Dysfunction in Primary Aldosteronism 74
Effects of renal revascularization on renal and cardiac function in hypertensive patients 72
Ipertensione arteriosa e poliglobulia in paziente con stenosi multiple delle arterie renali 70
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 70
Predictive factors of left ventricular mass changes after treatment of primary aldosteronism 70
null 70
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 69
Association of a prothrombotic state with the metabolic syndrome in essential hypertensive patients 68
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma 68
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature 68
Plasma aldosterone levels are related to urinary albumin excretion in hypertensive patients 67
Effects of omega-3 PUFA on plasma lipoprotein(a) in hypertensive patients 65
Left ventricular dysfunction and the intima-media thickness: a Tissue-Doppler study 64
Insulin resistance in the early stages of renal failure: implication for cardiovascular risk 64
Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study 64
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 64
Intima-media thickness and left ventricular dysfunction: a Tissue-Doppler echocardiographic study 63
Relationship between plasma aldosterone levels and albuminuria in hypertensive patients 63
Endothelial function in patients with non-alcoholic fatty liver disease 63
Totale 9.585
Categoria #
all - tutte 53.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.336 0 0 116 480 261 691 448 457 238 303 66 276
2020/20212.441 69 243 68 315 79 333 136 278 411 81 292 136
2021/20221.596 76 182 64 125 47 55 85 96 22 256 307 281
2022/20231.649 251 95 31 184 139 486 6 92 234 24 55 52
2023/2024520 91 32 41 9 82 58 23 12 70 20 8 74
2024/2025458 80 265 113 0 0 0 0 0 0 0 0 0
Totale 14.673